Just a couple years ago bpth raised funds at $3.25 per share. Since then we have not had any negative results from testing. So, why are we valued at 1/10 the value now?
PN failing to do his job well. If you honestly believe anything else then you are a fool.
People that come on here saying he is doing good or saying just wait, we are almost there, are not real shareholders with any experience with this company. They are either short term traders or stock pumpers.
PN needs to go for this company to advance or for bpth to be able to work a deal with a legitimate pharmaceutical company.
My opinion. I am not wrong.
News 
Market Data 
Discover 
